BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients

被引:27
作者
Berastegui, Cristina [1 ]
Gomez-Olles, Susana [1 ,2 ]
Sanchez-Vidaurre, Sara [1 ]
Culebras, Mario [1 ]
Monforte, Victor [1 ,2 ]
Lopez-Meseguer, Manuel [1 ]
Bravo, Carlos [1 ,2 ]
Ramon, Maria-Antonia [1 ]
Romero, Laura [3 ]
Sole, Joan [3 ]
Cruz, Maria-Jesus [1 ,2 ]
Roman, Antonio [1 ,2 ]
机构
[1] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Serv Pneumol, Barcelona, Spain
[2] Ciber Enfermedades Resp Ciberes, Barcelona, Spain
[3] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Serv Cirurg Torac, Barcelona, Spain
关键词
BOS; bronchoalveolar lavage; chronic rejection; cytokines; RAS; BRONCHIOLITIS-OBLITERANS-SYNDROME; BRONCHOALVEOLAR LAVAGE; COMPUTED-TOMOGRAPHY; SYNDROME RAS; REJECTION; HEART; EXPRESSION; THERAPY; TH1; AZITHROMYCIN;
D O I
10.1111/ctr.12898
中图分类号
R61 [外科手术学];
学科分类号
摘要
The long-term success of lung transplantation (LT) is limited by chronic lung allograft dysfunction (CLAD). Different phenotypes of CLAD have been described, such as bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS). The purpose of this study was to investigate the levels of cytokines and chemokines in bronchoalveolar lavage fluid (BALF) as markers of these CLAD phenotypes. BALF was collected from 51 recipients who underwent (bilateral and unilateral) LT. The study population was divided into three groups: stable (ST), BOS, and RAS. Levels of interleukin (IL)-4, IL-5, IL-6, IL-10, IL-13, tumor necrosis factor alpha (TNF-), interferon-gamma (IFN-), and granulocyte-macrophage colony-stimulating factor (GM-CSF) were measured using the multiplex technology. BALF neutrophilia medians were higher in BOS (38%) and RAS (30%) than in ST (8%) (P=.008; P=.012). Regarding BALF cytokines, BOS and RAS patients showed higher levels of INF- than ST (P=.02; P=.008). Only IL-5 presented significant differences between BOS and RAS (P=.001). BALF neutrophilia is as a marker for both CLAD phenotypes, BOS and RAS, and IL-5 seems to be a potential biomarker for the RAS phenotype.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Chronic lung allograft dysfunction
    Anupam Kumar
    Puneet Singh Garcha
    Indian Journal of Thoracic and Cardiovascular Surgery, 2022, 38 : 318 - 325
  • [42] Pharmacotherapy of chronic lung allograft dysfunction post lung transplantation
    Evans, Rickey A.
    Walter, Krysta S.
    Lobo, Leonard Jason
    Coakley, Raymond
    Doligalski, Christina T.
    CLINICAL TRANSPLANTATION, 2022, 36 (08)
  • [43] Impact of Transplant Body Mass Index and Post-Transplant Weight Changes on the Development of Chronic Lung Allograft Dysfunction Phenotypes
    Beauchamp-Parent, Caroline
    Jomphe, Valerie
    Morisset, Julie
    Poirier, Charles
    Lands, Larry C.
    Nasir, Basil S.
    Ferraro, Pasquale
    Mailhot, Genevieve
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (06) : 1420 - 1428
  • [44] Antithymocyte Globulin Treatment for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients: Experience From a National Reference Transplant Center
    Margallo Iribarnegaray, Juan
    De Pablo Gafas, Alicia
    Alonso Moralejo, Rodrigo
    Quezada Loaiza, Carlos Andres
    Revuelta Salgado, Fernando
    Pina Maiquez, Isabel
    Perez Gonzalez, Virginia Luz
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (09) : 2710 - 2717
  • [45] The Role of Galectins in Chronic Lung Allograft Dysfunction
    D'Alessandro, Miriana
    Bergantini, Laura
    Fossi, Antonella
    De Vita, Elda
    Perillo, Felice
    Luzzi, Luca
    Paladini, Piero
    Sestini, Piersante
    Rottoli, Paola
    Bargagli, Elena
    Bennett, David
    LUNG, 2021, 199 (03) : 281 - 288
  • [46] Restrictive chronic lung allograft dysfunction: Where are we now?
    Verleden, Stijn E.
    Ruttens, David
    Vandermeulen, Elly
    Bellon, Hannelore
    Van Raemdonck, Dirk E.
    Dupont, Lieven J.
    Vanaudenaerde, Bart M.
    Verleden, Geert
    Vos, Robin
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (05) : 625 - 630
  • [47] Montelukast for chronic lung allograft dysfunction: Not quite the "Full Monty"
    Glanville, Allan R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (05) : 528 - 529
  • [48] Chronic Lung Allograft
    Venado, Aida
    Kukreja, Jasleen
    Greenland, John R.
    THORACIC SURGERY CLINICS, 2022, 32 (02) : 231 - 242
  • [49] Quantitative CT Correlates with Local Inflammation in Lung of Patients with Subtypes of Chronic Lung Allograft Dysfunction
    Ram, Sundaresh
    Verleden, Stijn E.
    Bell, Alexander J.
    Hoff, Benjamin A.
    Labaki, Wassim W.
    Murray, Susan
    Vanaudenaerde, Bart M.
    Vos, Robin
    Verleden, Geert M.
    Kazerooni, Ella A.
    Galban, Stefanie
    Hatt, Charles R.
    Han, Meilan K.
    Lama, Vibha N.
    Galban, Craig J.
    CELLS, 2022, 11 (04)
  • [50] Chronic lung allograft dysfunction: evolving practice
    Vos, Robin
    Verleden, Stijn E.
    Verleden, Geert M.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2015, 20 (05) : 483 - 491